Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-025210
Filing Date
2008-04-22
Accepted
2008-04-22 19:44:14
Documents
2
Period of Report
2008-04-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4141
2 POA DOCUMENT poa.txt EX-24.4_236695 2827
  Complete submission text file 0001209191-08-025210.txt   8790
Mailing Address 300 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address C/O DYAX CORP 300 TECHNOLOGY SQ CAMBRIDGE MA 02139 6172252500
GALLIKER STEPHEN S (Reporting) CIK: 0001249422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 08770362

Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations